Added to YB: 2024-06-23
Pitch date: 2024-06-23
GRAL:US [bullish]
GRAIL, Inc.
+183.66%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
Market Cap
$2.0B
Pitch Price
$18.24
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.13
P/E
-4.38
EV/Sales
7.57
Sector
Biotechnology
Category
N/A
Show full summary:
GRAIL Inc GRAL:US
A summary for this pitch has not been created yet.
Read full article (0 min)